Isoray Stock News

PolarityTE, Inc. (NASDAQ:PTE) with the stream of -4.05% also noticed, India Isoray, Inc. (AMEX:ISR) encountered a rapid change of -4.52% in the last hour of Monday’s trading session. PolarityTE, Inc. … The post Exceptional Stock in Review: PolarityTE, Inc. (NASDAQ:PTE), Isoray, Inc. (AMEX:ISR) appeared first on Stocks Equity .

Investigators from the University of Pittsburgh School of Medicine have published a clinical study demonstrating favorable outcomes for localized intermediate-risk prostate cancer patients treated with IsoRay Inc''s (NYSE: ISR ) Cesium-131 brachytherapy known as Cesium Blu. Brachytherapy is a localized internal radiation therapy in which seeds, ribbons, or capsules containing … Full story available on Benzinga.com

Qualigen Therapeutics, Inc. (NASDAQ:QLGN) with the stream of 5.73% also noticed, India Isoray, Inc. (AMEX:ISR) encountered a rapid change of 3.76% in the last hour of trading session. Qualigen Therapeutics, … The post Sizzling Stock Update: Qualigen Therapeutics, Inc. (NASDAQ:QLGN), Isoray, Inc. (AMEX:ISR) appeared first on Stocks Equity .

Isoray, Inc. (NYSE:ISR) Q2 2022 Earnings Conference Call Feb 08, 2022, 04:30 PM ET Company Participants Mark Levin - IR Lori Woods - CEO Jonathan Hunt - CFO Conference Call Participants

IsoRay (ISR) delivered earnings and revenue surprises of 0% and 8.06%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

IsoRay press release (ISR): Q2 GAAP EPS of -$0.01 in-line.Revenue of $2.82M (+19.5% Y/Y) beats by $0.02M.Shares -0.39%.Gross profit as a percentage of revenues was 43.3% for the

Revenue Increased 19% Year-Over-Year Prostate Brachytherapy Revenue Increased 13% Year-Over-Year

Isoray, Inc. (ISR) CEO Lori Woods on Q2 2022 Results - Earnings Call Transcript

IsoRay (ISR) delivered earnings and revenue surprises of 0% and 8.06%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

IsoRay (NYSE:ISR) is scheduled to announce Q2 earnings results on Tuesday, February 8th, after market close.The consensus EPS Estimate is -$0.01 and the consensus Revenue Estimate is $2.8M

IsoRay (ISR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Conference Call is Tuesday, February 8, 2022 at 4:30 p.m. ET/1:30 p.m. PT Conference Call is Tuesday, February 8, 2022 at 4:30 p.m. ET/1:30 p.m. PT

Conformis, Inc. (NASDAQ:CFMS) with the stream of -2.17% also noticed, India Isoray, Inc. (AMEX:ISR) encountered a rapid change of -2.17% in the last hour of Thursdays trading session. Conformis, Inc. The post Alarming Stock: Conformis, Inc. (NASDAQ:CFMS), Isoray, Inc. (AMEX:ISR) appeared first on Stocks Equity .

Catalyst Biosciences, Inc. (NASDAQ:CBIO) with the stream of -1.42% also noticed, India Isoray, Inc. (AMEX:ISR) encountered a rapid change of -1.45% in the last hour of Tuesdays trading session. Catalyst The post Have a gripe on this: Catalyst Biosciences, Inc. (NASDAQ:CBIO), Isoray, Inc. (AMEX:ISR) appeared first on Stocks Equity .

Isoray, Inc. (NYSEAMERICAN:ISR)s stock price passed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $0.00 and traded as high as $0.45. Isoray shares last traded at $0.43, with a volume of 546,792 shares changing hands. ISR has been the topic of []